Open AccessPhase 1 Study Evaluating Safety, Tolerability, Pharmacokinetics and Immunogenicity of REGN2222 in Healthy Adults: A New Human Monoclonal RSV-F Antibody for RSV Prevention
Author(s) -
Sumathi Sivapalasingam,
David Caballero-Perez,
Matthew C. Houghton,
Feng Yang,
John D. Davis,
Bo Gao,
Gregory P. Geba
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.628
Subject(s) - medicine , immunogenicity , tolerability , pharmacokinetics , monoclonal antibody , adverse effect , virology , antibody , pharmacology , monoclonal , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom